Insights into the regulation of NAD(+) levels and Sirtuin1 activity: Genistein, an anti-cancer drug from Soya, suppresses the expression of NAMPT, the rate-limiting enzyme for NAD(+) biosynthesis, via up regulation of its target gene, 20/April/2014, 6.04 am

Insights into the regulation of NAD(+) levels and Sirtuin1 activity: Genistein, an anti-cancer drug from Soya, suppresses the expression of NAMPT, the rate-limiting enzyme for NAD(+) biosynthesis, via up regulation of its target gene, 20/April/2014, 6.04 am

Insights into the regulation of NAD(+) levels and Sirtuin1 activity: Genistein, an anti-cancer drug from Soya, suppresses the expression of NAMPT, the rate-limiting enzyme for NAD(+) biosynthesis, via up regulation of its target gene, 20/April/2014, 6.04 am 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated by: Dr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To cite: Boominathan, Insights into the regulation of NAD(+) levels and Sirtuin1 activity: Genisteinan, an anti-cancer drug from Soya,  suppresses the expression of  NAMPT, the  rate-limiting enzyme for NAD(+) biosynthesis, via up regulation of its target gene, 20/April/2014, 6.04 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Share
Start Typing